Dr. Incordona is the Assistant Director of In Vitro Pharmacology. Before joining Bio-Quant she was the Head of therapeutic antibodies and fusion molecules at Peregrine Pharmaceuticals. Prior to Peregrine, Dr. Incordona was part of the oncology group at the Genomic Institute of the Novartis Research Foundation (GNF). Ahead of joining GNF, she worked at Biogen Idec in the discovery and validation of therapeutics. Dr. Incordona is highly published in the filed of Immunology and Oncology and holds a Ph.D. in Immunology/Oncology from the University of Paris VII , France and a postdoctoral fellowship in oncology from Cedars-Sinai Medical Centre.